Artificial Intelligence-assisted Colonoscopy on Detection of Missed Proximal Lesions

NCT ID: NCT04294355

Last Updated: 2022-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

216 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-01

Study Completion Date

2022-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective multi-center randomized study is to determine whether the use of artificial intelligence (AI)-assistance could reduce the miss rates of polyps and adenomas in the proximal colon during tandem examination

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Centers

1. Queen Mary Hospital, Hong Kong, China (Co-ordinating Center)
2. Tan Tock Seng Hospital, Singapore, Singapore
3. Institute of Gastroenterology and Hepatology, Vietnam Union of Science and Technology Association, Hanoi, Vietnam

Study population

Inclusion:

All adult patients, aged 40 or above, undergoing outpatient colonoscopy in the participating centers will be recruited.

Exclusion:

* history of inflammatory bowel disease
* history of colorectal cancer
* previous bowel resection (apart from appendectomy)
* Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes
* bleeding tendency or severe comorbid illnesses for which polypectomy is considered unsafe.

Post-randomization exclusion:

* Cecum could not be intubated for various reasons
* Boston Bowel Preparation Scale (BBPS) score of the proximal colon is \<2

Study design This is a prospective randomized trial comparing the miss rates of proximal colonic lesions by AI assisted colonoscopy or conventional colonoscopy (Fig. 1). The study will be conducted in the Endoscopy Centre of the participating hospitals.

Randomization Eligible patients in each center will be randomly allocated in a 1:1 ratio to undergo tandem colonoscopy of the proximal colon first with AI-assistance and follow by conventional white light colonoscopy (Group 1) or conventional white light colonoscopy without AI assistance follow by conventional colonoscopy (Group 2). Proximal colon refers to colonic segment proximal to the splenic flexure. Randomization will be conducted in blocks of 4 by computer generated random sequences and stratified according to indications of colonoscopy (symptomatic vs screening/surveillance). Patients will be blinded to the group assignment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colon Adenoma Colon Polyp

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Prospective randomized design
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Artificial intelligence-Assisted colonoscopy

Tandem colonoscopy of proximal colon assisted with artificial intelligence followed by conventional colonoscopy

Group Type EXPERIMENTAL

Artificial intelligence-Assisted colonoscopy

Intervention Type DEVICE

Artificial intelligence-Assisted colonoscopy for detection of colonic polyp

Conventional colonoscopy

Intervention Type PROCEDURE

Conventional colonoscopy

Conventional colonoscopy

Tandem conventional colonoscopy of proximal colon followed by usual conventional colonoscopy

Group Type ACTIVE_COMPARATOR

Conventional colonoscopy

Intervention Type PROCEDURE

Conventional colonoscopy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Artificial intelligence-Assisted colonoscopy

Artificial intelligence-Assisted colonoscopy for detection of colonic polyp

Intervention Type DEVICE

Conventional colonoscopy

Conventional colonoscopy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adult patients, aged 40 or above, undergoing outpatient colonoscopy in the participating centers will be recruited

Exclusion Criteria

* history of inflammatory bowel disease
* history of colorectal cancer
* previous bowel resection (apart from appendectomy)
* Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes
* bleeding tendency or severe comorbid illnesses for which polypectomy is considered unsafe.
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tan Tock Seng Hospital

OTHER

Sponsor Role collaborator

Institute of Gastroenterology and Hepatology, Vietnam

OTHER

Sponsor Role collaborator

The University of Hong Kong

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ka Luen, Thomas Lui, MBBS

Role: PRINCIPAL_INVESTIGATOR

Queen Mary Hospital, the University of Hong Kong

Wai Keung Leung, MD

Role: STUDY_DIRECTOR

Queen Mary Hospital, the University of Hong Kong

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Queen Mary Hospital

Hong Kong, , China

Site Status

Tan Tock Seng Hospital

Singapore, , Singapore

Site Status

Institute of Gastroenterology and Hepatology

Hanoi, , Vietnam

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China Singapore Vietnam

References

Explore related publications, articles, or registry entries linked to this study.

Lui TKL, Hang DV, Tsao SKK, Hui CKY, Mak LLY, Ko MKL, Cheung KS, Thian MY, Liang R, Tsui VWM, Yeung CK, Dao LV, Leung WK. Computer-assisted detection versus conventional colonoscopy for proximal colonic lesions: a multicenter, randomized, tandem-colonoscopy study. Gastrointest Endosc. 2023 Feb;97(2):325-334.e1. doi: 10.1016/j.gie.2022.09.020. Epub 2022 Oct 5.

Reference Type DERIVED
PMID: 36208795 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UW 19-713

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Application of AI in Polypectomy
NCT04485715 UNKNOWN NA